SCHEMBL4318147

SCHEMBL4318147

CC[C@@H](N)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL362849 1.00
SCHEMBL4320194 1.00
Hydrochloric Acid SCHEMBL4319087 0.96
Bromide SCHEMBL9752773 0.96
Hydrochloric Acid SCHEMBL1840679 0.96
Bromide SCHEMBL9752774 0.96
Hydrochloric Acid SCHEMBL6266065 0.96
Ammonia Solution, Strong SCHEMBL5551404 0.96
Hydrochloric Acid SCHEMBL4319815 0.96
SCHEMBL27613149 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113461926-B Chemical synthesis method of poly beta-hydroxy fatty acid ester 大连理工大学 2022-08-02 CN claimed
CN-113461926-A Chemical synthesis method of poly beta-hydroxy fatty acid ester 大连理工大学 2021-10-01 CN claimed
US-8664228-B2 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases NOVARTIS AG (CH) 2014-03-04 US claimed
EP-2285785-B1 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES NOVARTIS AG (CH) 2012-09-05 EP claimed
WO-2009138378-A1 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES NOVARTIS AG (CH) 2009-11-19 WO claimed
CN-113461926-B Chemical synthesis method of poly beta-hydroxy fatty acid ester 大连理工大学 2022-08-02 CN disclosed
CN-113461926-A Chemical synthesis method of poly beta-hydroxy fatty acid ester 大连理工大学 2021-10-01 CN disclosed
US-20160271082-A1 BACTERIAL EFFLUX PUMP INHIBITORS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2016-09-22 US disclosed
US-20160271081-A1 BACTERIAL EFFLUX PUMP INHIBITORS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2016-09-22 US disclosed
US-8664228-B2 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases NOVARTIS AG (CH) 2014-03-04 US disclosed
EP-2285785-B1 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES NOVARTIS AG (CH) 2012-09-05 EP disclosed
WO-2012012843-A1 MODULATORS OF PROTEASE ACTIVATED RECEPTORS THE UNIVERSITY OF QUEENSLAND (AU) 2012-02-02 WO disclosed
WO-2009138378-A1 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES NOVARTIS AG (CH) 2009-11-19 WO disclosed
EP-2103619-A1 IMIDAZOTHIAZOLE DERIVATIVES Daiichi Sankyo Company, Limited (JP) 2009-09-23 EP disclosed
US-7371733-B2 Anti bacterial compounds UTAH STATE UNIVERSITY (US) 2008-05-13 US disclosed
EP-1127889-B1 Chiral molecular magnet and manufacturing method of the same NAT INST NATURAL SCIENCES (JP) 2004-10-20 EP disclosed
US-6355820-B1 MONOCRYSTAL MAGNET POURING SOLUTIONS OF DIAMINE, MANGANATE SALT, DEAERATION SOLVENT, HEXACYANOCHROMATE SALT AND PRECIPITATION OF MANGANESE, HEXACYANO CHROMIUM WITH DIAMINO LIGAND OKAZAKI NATIONAL RESEARCH INSTITUTES (JP) 2002-03-12 US disclosed
EP-1127889-A2 Chiral molecular magnet and manufacturing method of the same Okazaki National Research Institutes (JP) 2001-08-29 EP disclosed